Ruan Yiping, Hong Fuyuan, Wu Jiabin, Lin Miao, Wang Chen, Lian Fayang, Cao Fang, Yang Guokai, Huang Lanting, Huang Qiaoyun
Department of Nephrology, Fujian Provincial Clinical College, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, China.
Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
J Nephrol. 2022 May;35(4):1113-1121. doi: 10.1007/s40620-022-01273-5. Epub 2022 Mar 15.
BACKGROUND/AIMS: The aim of the study was to investigate the clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy (IgAN) patients with crescents.
Four hundred and fifty-eight biopsy-proven primary IgAN patients included between January 2010 and October 2021 for a retrospective analysis were divided into three groups according to crescent score of the updated Oxford classification: C0 group (n = 255), C1 group (n = 187) and C2 group (n = 16). The clinicopathological features and renal outcomes were recorded. In univariate and multivariate models, the association between crescents and renal outcome and C2-associated clinical factors were analyzed.
Patients with a higher proportion of crescents presented worse clinical characteristics with regard to kidney function, proteinuria, hematuria, hemoglobin, uric acid, cholesterol, and serum albumin, while global glomerulosclerosis, segmental adhesion, tuft necrosis, segmental glomerulosclerosis (S1), tubular atrophy/interstitial fibrosis (T1/2), and lymphocyte and monocyte infiltration were more severe. By multivariate logistic regression analysis, eGFR (OR 0.981, 95% CI 0.964-0.999, P = 0.039), proteinuria (OR 1.655, 95% CI 1.180-2.321, P = 0.004), and hematuria (OR 4.752, 95% CI 1.426-15.835, P = 0.011) were significantly associated with C2. C2 was significantly associated with poorer renal survival even in patients receiving immunosuppressive therapy. Nevertheless, only eGFR at baseline, rather than crescents, was an independent predictor for renal survival in multivariate Cox analyses.
IgAN patients with crescents presented more severe clinical and pathological features. Renal function, proteinuria and hematuria contributed to identifying patients with crescents. Crescents were associated with poorer renal survival, even in patients receiving immunosuppressive therapy, but it was not an independent predictor.
背景/目的:本研究旨在调查伴有新月体的IgA肾病(IgAN)患者的临床病理特征、危险因素及肾脏转归。
对2010年1月至2021年10月期间纳入的458例经活检证实的原发性IgAN患者进行回顾性分析,根据更新的牛津分类法中的新月体评分将其分为三组:C0组(n = 255)、C1组(n = 187)和C2组(n = 16)。记录临床病理特征及肾脏转归。在单因素和多因素模型中,分析新月体与肾脏转归以及与C2相关的临床因素之间的关联。
新月体比例较高的患者在肾功能、蛋白尿、血尿、血红蛋白、尿酸、胆固醇和血清白蛋白方面表现出更差的临床特征,而全球肾小球硬化、节段性粘连、肾小球毛细血管袢坏死、节段性肾小球硬化(S1)、肾小管萎缩/间质纤维化(T1/2)以及淋巴细胞和单核细胞浸润更为严重。通过多因素logistic回归分析,估算肾小球滤过率(eGFR)(比值比[OR] 0.981,95%置信区间[CI] 0.964 - 0.999,P = 0.039)、蛋白尿(OR 1.655,95% CI 1.180 - 2.321,P = 0.004)和血尿(OR 4.752,95% CI 1.426 - 15.835,P = 0.011)与C2显著相关。即使在接受免疫抑制治疗的患者中,C2也与较差的肾脏生存率显著相关。然而,在多因素Cox分析中,仅基线时的eGFR而非新月体是肾脏生存的独立预测因素。
伴有新月体的IgAN患者表现出更严重的临床和病理特征。肾功能、蛋白尿和血尿有助于识别伴有新月体的患者。新月体与较差的肾脏生存率相关,即使在接受免疫抑制治疗的患者中也是如此,但它不是独立的预测因素。